Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver nanoparticle gel vs triamcinolone ointment for lichen planus lesion healing
IRCT20230823059242N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of silver nanoparticles and triamcinolone in lichen planus (LP) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
silver nanoparticlestriamcinolone
03
Conditions
lichen planus (LP)
Beyond the preview
Go deeper on IRCT20230823059242N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230823059242N1.